People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the makers of Ozempic, Wegovy, Mounjaro and Zepbound.

If you’re paying cash for a GLP-1, prices will fall to $350 per month or lower, according to a White House press release, with reports that it could trend down to $245 within two years. The pill version of Wegovy — pending approval from the Food and Drug Administration — could cost about $150 per month.

That’s a shift from today’s prices, where most GLP-1 drugs list for more than $1,000. Even warehouse stores like Sam’s Club and Costco sell Ozempic and Wegovy for $499 out of pocket.

Enrolled in Medicare ? Weight-loss drugs will be priced at $245 with a $50 monthly copay, according to the announcement. But the bigger

See Full Page